Development of multiantigen vaccines to prevent the development of lung adenocarcinomas driven by either K-RAS or egfr oncoproteins in mice.
Ended Awarded Last action
- Contract number
- HHSN26100002
- Awardee
-
The Medical College Of Wisconsin, Inc. UEI E8VWJXMMUQ67
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $633,080
Award facts
- Opportunity
-
- N01CN5500347 Solicitation number
- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015
- Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
- Contract value 100% obligated
- $633,080.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Wauwatosa, WI 53226, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$1 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $633,081 |
About this award
The Medical College of Wisconsin, Inc. was awarded a $633,080.38 delivery order against the PREVENT Cancer Program master IDIQ contract to develop multiantigen vaccines preventing lung adenocarcinomas driven by K-Ras or EGFR oncoproteins in mice. The National Cancer Institute, part of the Department of Health and Human Services, issued the award under its PRECLINICAL PREVENT CANCER PROGRAM focused on preclinical efficacy and intermediate endpoint biomarkers. Performance will occur in Milwaukee, Wisconsin through March 23, 2019. No set-aside designation applied to the firm fixed price order supporting the National Institutes of Health's efforts to prevent cancer through preclinical research.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to The Medical College Of Wisconsin, Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2015.
How much is contract HHSN26100002 worth?
The government has obligated $633,080 on HHSN26100002.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN261201500037I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award